Team Portfolio Raise Essays

F4/Awareness Capital/Activity

Awareness Capital Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

News

Cybin Inc., a portfolio company of Awareness Capital, completed a legal name change to Helus Pharma Inc. effective October 1, 2026, after shareholder approval on September 22, 2026. The company trades under the ticker HELP on NASDAQ and Cboe Canada.

Cybin Inc.

Cybin Inc.Awareness Capital

ir.helus.comOCT 1, 2026

OCT 1, 2026

Awareness Capital | Activity | F4

Investment

Participated in Hemispheric's $52M funding round to launch Descartes, a frontier NeuroAI model for decoding brain activity.

Hemispheric

Hemispheric Awareness Capital

businesswire.comJUL 15, 2026

JUL 15, 2026

Essay

Published a thesis essay arguing that brain and mental health science has matured to the point that capital allocation must catch up.

In brain and mental health, the science is here. Now capital must follow.

Awareness Capital

awarenesscapital.comMAY 1, 2026

awarenesscapital.com

MAY 1, 2026

Milestone

Portfolio company Ampa closed an oversubscribed $8.5M round and launched nationwide rollout of its FDA-cleared portable TMS brain-stimulation system.

Ampa

Ampa Awareness Capital

prnewswire.comOCT 2025

OCT 2025

Exit

Portfolio company Gilgamesh Pharmaceuticals' lead psychedelic asset bretisilocin was acquired by AbbVie for up to $1.2B.

Gilgamesh Pharmaceuticals

Gilgamesh Pharmaceuticals Awareness Capital

news.abbvie.comAUG 25, 2025

AUG 25, 2025